Abstract submissions are now closed.
Abstract Body Format
Contents should include the following sections:
Background and Aims
Include one or two sentences to introduce the broad topic area and provide a reason for the study. Provide a clear statement of the aims of the study. A hypothesis could be included in this section
It may also be appropriate to add references to cited literature here. References will be included in the word limit. Authors are advised to keep references to a minimum, and to use an abbreviated referencing system, i.e. First author et al., no title, year of publication, abbreviated journal title, volume, pages.
In this section information on participants (and /or subjects) should be provided. This may include the number of participants, demographic information such as age and gender as well as the method of recruitment. (ie a random sample or a convenient sample). Study inclusion and exclusion criteria should be included in this section as well as a sample size calculation if presenting a randomised clinical trial. Measures and procedures used in the study are described in this section. Descriptions of analyses appear in the methods section.
The purpose of the result section is to provide a description of the main findings of the study. Reference to potential results that were unavailable at the time that the abstract was submitted will not be acceptable. Submitted abstracts must include actual results. Data from additional recruitment or updated analyses after abstract submission can be reported in the poster or oral presentation. Results should be expressed as means or medians and the spread of the results indicated as ranges, standard deviations or 95% confidence intervals as appropriate. Probability values must be included, but are not sufficient of themselves without descriptive statistics (means, etc).
In this section you should provide statements of interpretation and implication of findings, as well as comparison with previous literature. It should not be a simple restatement of the results.
There are some cases where this format requires modification, although authors should try as best as possible to adapt their abstract to fit within these 4 headings.
* * *
All abstracts will be reviewed by the NSANZ ASM Committee within 2-4 weeks of the closing date.
Some abstracts will need to be amended and you may be contacted by the Reviewer to discuss these changes. It is the intention of the Committee to use the amendment process to assist authors to improve their abstract writing skills. The NSANZ ASM is an opportunity for new researchers to present their findings, and the Committee is eager to assist in the development of researchers investigating neuromodulation.
All presenters must register for the conference by the Early Bird Registration Deadline - Friday 24 February 2017, or the poster will be withdrawn from the program.
There is no funding or discounted registrations available for submitted abstracts.
For further information please contact the NSANZ Conference Secretariat
DC Conferences Pty Ltd
P: 02 9954 4400